Fysicon B.V. has been acquired by Canon Medical Systems
Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.
Fysicon is a developer and assembler of innovative medical software and hardware for hospitals, clinics and research institutes. Since its foundation in 1996 and with unique advanced technologies and clinical evidence, Fysicon has developed and manufactured product families such as cardiovascular monitoring systems. Fysicon's CEO Linda Elberse, said: "Now we are ready to take our business to the next level, and we truly appreciate the Dutch team's role in helping to make it happen."
Canon Medical Systems Corporation develops medical diagnostic imaging systems and medical solutions. It offers angiography, computed tomography, magnetic resonance, ultrasound, X-ray, nuclear medicine, healthcare imaging informatics systems and RF amplifier components. The company was founded in 1930 and is headquartered in Otawara-shi, Japan, with subsidiaries in Japan, North America, South America, Europe, Africa, the Mid-East, Asia, and Oceania.
Oaklins' healthcare team in the Netherlands advised the selling shareholder throughout the process.
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more